[Anesthesia with flunitrazepam/fentanyl in the severe coronary patient. Hemodynamic study]

Area of Science:

• Anesthesiology
• Cardiovascular Surgery
• Pharmacology

Context:

• Patients with advanced heart failure (NYHA class III or IV) undergoing coronary bypass surgery require careful anesthetic management.
• Understanding the hemodynamic effects of anesthetic agents is crucial for patient safety in high-risk cardiac procedures.

Purpose:

• To evaluate the hemodynamic impact of administering flunitrazepam, fentanyl, and nitrous oxide (N2O) anesthesia during coronary bypass surgery.
• To assess the effects of this anesthetic combination on cardiac index and systolic vascular resistance in patients with compromised ventricular function.

Summary:

• Twenty-three patients with NYHA class III or IV heart failure received anesthesia with flunitrazepam (30 µg/kg) and fentanyl (20 µg/kg) combined with N2O for coronary bypass surgery.
• Hemodynamic monitoring revealed a 30% decrease in cardiac index post-induction, while systolic vascular resistance remained stable.
• The observed negative inotropic effect is attributed to the anesthetic combination, potentially exacerbated by the patients' pre-existing poor ventricular function, leading to an underestimation of vascular filling.

Impact:

• The findings suggest that the combination of flunitrazepam, fentanyl, and N2O may induce significant negative inotropic effects in patients with severe heart failure.
• This highlights the need for careful consideration of anesthetic choices and hemodynamic monitoring in high-risk cardiac surgical patients.
• Further research may explore alternative anesthetic strategies to mitigate adverse hemodynamic changes in this population.